Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MolecuLightDX Measurement Feature Clinical Validation

NCT: NCT06682923 · COMPLETED

NCT IDNCT06682923
StatusCOMPLETED
Start Date2024-10-23
Completion2025-02-20
SponsorMolecuLight Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, single-arm, paired clinical evaluation of the MolecuLightDX device in the measurement of surface wounds in patients.

Frequently Asked Questions

What is MolecuLightDX Measurement Feature Clinical Validation?

MolecuLightDX Measurement Feature Clinical Validation is a clinical trial registered under NCT06682923. Current status: COMPLETED.

What is the status of NCT06682923?

The current status of NCT06682923 (MolecuLightDX Measurement Feature Clinical Validation) is: COMPLETED.

When did MolecuLightDX Measurement Feature Clinical Validation start?

MolecuLightDX Measurement Feature Clinical Validation started on 2024-10-23.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.